The Haemostatic Agents Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Haemostatic Agents Market is estimated to be USD X.XX billion in 2016 and predicted to rise to USD XX.XX billion by 2021 with a CAGR of XX.XX%. The market is segmented by Type (Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants and Others), by Treatment (Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery and Others), by End User (Hospitals, Surgery Centres, Nursing Homes and Others). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The major drivers of the Haemostatic Agents market are the rising prevalence of diseases and rising awareness regarding latest medical practices. Other drivers include increasing health consciousness among consumers, use of new inventions and enhanced technologies. As for the restraints of the market, the high procedural costs and the unfavorable reimbursement policies are the main ones. The lack of proper awareness in the lesser developed parts of the world is also a factor.
In 2016 the market was dominated by the hospitals segment being the largest revenue generator. The requirement of haemostats in hospitals in large quantities is the main reason for this. Haemostats are also in large demand in surgical centres and this is expected to show the highest growth rate among segments.
The Haemostatic Agents Market is dominated by North America in 2016 with the region accounting for 36% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. Another promising region for the market is Latin America, which is expected to show high growth rates in coming years.
High investment from top players and increasing R&D spending are likely to provide ample opportunities to the industry players across regions. Key market players include Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies and Z-Medica.
Browse through the full report at “https://www.marketdataforecast.com/market-reports/haemostatic-agents-market-4529/” and checkout our recent reports in the Healthcare category at “https://www.marketdataforecast.com/category/healthcare-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.